SciELO - Scientific Electronic Library Online

 
vol.30 número3Detección de anticuerpos séricos de influenza aviar tipo A, enfermedad de Newcastle, bronquitis infecciosa y laringotraqueitis infecciosa en aves acuáticas silvestres de tres lagunas andinas del EcuadorDeterminación de linfocitos T CD4, CD8 y Tγδ en la infección experimental con Brucella ovis índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

Compartir


Revista de Investigaciones Veterinarias del Perú

versión impresa ISSN 1609-9117

Resumen

FERRANTE, Marcos  y  WOSIACKI, Sheila R.. Efficacy of florfenicol for the treatment of infections by Pasteurella multocida and Mannheimia haemolitica in alpacas (Vicugna pacos). Rev. investig. vet. Perú [online]. 2019, vol.30, n.3, pp.1292-1300. ISSN 1609-9117.  http://dx.doi.org/10.15381/rivep.v30i3.15207.

The aim of the study was to evaluate the effect of florfenicol treatment at a dose of 20 mg/kg via i.m. in the treatment of infections caused by Pasteurela multocida and Mannheimia haemolitica in alpacas. The efficacy rate was determined according to the minimum inhibitory concentration (MIC) of the infecting bacterium. For this, a Monte Carlo simulation of pharmacokinetic parameters for 10 000 events and pharmacokinetic/ pharmacodynamic analysis (PK/PD) was performed. The estimated efficacy rates for P. multocida were 99, 20 and 1% and according to the MICs of strains 0.5, 1 and 2, respectively, while the estimated efficacy rates for M. haemolitica were 100, 95 and 3% and according to the CIM of strains 0.5, 1 and 2, respectively. The probability of obtaining the bacteriological cure after treatment decreased in a highly significant way for infections caused by bacteria with MICs higher than 0.5 µg/ml for P. multocida (p<0.01) and 1 µg/ml for M. haemolitica (p<0.01). The results showed the need to incorporate bacteriological isolation, the determination of the MIC and the optimization of the therapeutic dose according to the susceptibility of P. multocida and M. haemolitica strains in the therapeutic protocol to avoid therapeutic failures and consequently promote the development of bacterial resistance

Palabras clave : pharmacokinetic/pharmacodynamic modelling; Lama glama; South American camelids.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons